HealthEquity, Inc. (HQY) Earnings Call Transcripts

38 earnings calls from January 2020 to May 28, 2026

NasdaqGS US Health Care Health Care Providers and Services

HealthEquity, Inc.'s Latest Earnings Call - Q1 FY2027

In the first quarter of fiscal 2027, HealthEquity, Inc. (HQY) reported a 7% year-over-year increase in revenue, reaching $297.2 million, driven by record service and custodial revenues. The company raised its fiscal 2027 revenue guidance to between $1.41 billion and $1.42 billion, reflecting strong account growth and operational efficiencies. Adjusted EBITDA margin expanded to 46%, indicating improved profitability, while net income was reported at $69.4 million, or $0.82 per diluted share, signaling robust financial health and operational leverage.

Reported metrics

MetricValueContext
Revenue $297.2M (beat) vs $278.5M est, +7% YoY
Net Income $69.4M (beat) or $0.82 per diluted share, vs $0.70 est
Adjusted EBITDA $164.5M (positive) up 17% YoY, 46% of revenue
Service Revenue $122.9M (inline) up 3% YoY
Custodial Revenue $174.3M (positive) up 11% YoY
Annualized Yield on HSA Cash 3.84% (positive) vs 3.78% prior, reflecting higher rates

Guidance from management

HealthEquity raised its fiscal 2027 revenue guidance to between $1.41 billion and $1.42 billion, with GAAP net income expected between $242 million and $248 million, or $2.88 to $2.95 per share. Adjusted EBITDA is projected between $625 million and $633 million, reflecting confidence in continued growth.

What management said

Well, so marketplace has no real cost of acquisition or cost to serve. And so most of that flows through. But I think Jim and I repeatedly say there's no such thing as service gross margin. Our service costs which go against all of the things that we do go against all of revenue, not just service revenue. So just a bit of a clarification associated with how we think about that. But the incremental margin on a marketp...
— Scott Cutler, Q1 FY2027 earnings call
Yes. So I think you're speaking to the Allegis acquisition by UnitedHealth. So Allegis is a white-labeled software provider. We do not compete providing white-label products. We sell direct into our client base. We will note that what we will be watching for are those existing clients that may view that tie-up as competitive in terms of sharing data or opportunity, which could be interesting for us. And so we'll trac...
— Scott Cutler, Q1 FY2027 earnings call

What analysts pressed on

Analysts expressed concerns regarding the potential impact of slowing healthcare utilization on revenue, particularly in interchange revenue growth. There were also questions about the sustainability of recent efficiency gains and how they might affect future service costs.

Main topics on the call

Read the full HealthEquity, Inc. transcript (Q1 FY2027) → Summary generated from the call transcript; every figure above is stated by management on the record.

About HealthEquity, Inc.

HealthEquity, Inc. (HQY) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 38 calls on record spanning January 15, 2020 to May 28, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 38 HealthEquity, Inc. earnings call transcripts on record, spanning January 15, 2020 to May 28, 2026. Based on this history, HealthEquity, Inc. reports quarterly. The most recent call on file is dated May 28, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
HQY
Exchange
NasdaqGS
Country
US
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
38
First call
January 15, 2020
Most recent
May 28, 2026
Reporting cadence
quarterly
Quarter Date
Q1 FY2027 May 28, 2026 Read transcript
Q4 FY2026 Mar 17, 2026 Read transcript
Company Conference Presentations Jan 13, 2026 Read transcript
Q3 FY2026 Dec 3, 2025 Read transcript
Q2 FY2026 Sep 2, 2025 Read transcript
Q1 FY2026 Jun 3, 2025 Read transcript
Q4 FY2025 Mar 18, 2025 Read transcript
Company Conference Presentations Jan 15, 2025 Read transcript
Q3 FY2025 Dec 9, 2024 Read transcript
Special Calls Nov 12, 2024 Read transcript
Q2 FY2025 Sep 3, 2024 Read transcript
Q1 FY2025 Jun 3, 2024 Read transcript
Q4 FY2024 Mar 19, 2024 Read transcript
Analyst/Investor Day Feb 22, 2024 Read transcript
Company Conference Presentations Jan 10, 2024 Read transcript
Q3 FY2024 Dec 5, 2023 Read transcript
Q2 FY2024 Sep 5, 2023 Read transcript
Shareholder/Analyst Calls Jun 22, 2023 Read transcript
Q1 FY2024 Jun 5, 2023 Read transcript
Q4 FY2023 Mar 21, 2023 Read transcript
Company Conference Presentations Jan 11, 2023 Read transcript
Q3 FY2023 Dec 6, 2022 Read transcript
Q1 FY2023 Jun 6, 2022 Read transcript
Q4 FY2022 Mar 22, 2022 Read transcript
Sales/Trading Statement Calls Feb 22, 2022 Read transcript
Company Conference Presentations Jan 12, 2022 Read transcript
Q3 FY2022 Dec 6, 2021 Read transcript
Q2 FY2022 Sep 8, 2021 Read transcript
Shareholder/Analyst Calls Jun 24, 2021 Read transcript
Q1 FY2022 Jun 7, 2021 Read transcript
Q4 FY2021 Mar 15, 2021 Read transcript
Sales/Trading Statement Calls Feb 8, 2021 Read transcript
Q3 FY2021 Dec 7, 2020 Read transcript
Q2 FY2021 Sep 8, 2020 Read transcript
Q1 FY2021 Jun 2, 2020 Read transcript
Q4 FY2020 Mar 16, 2020 Read transcript
Sales/Trading Statement Calls Feb 18, 2020 Read transcript
Company Conference Presentations Jan 15, 2020 Read transcript